Haitong Capital
Shanghaihtcc.fund
Overview
Haitong Capital is a private equity investment subsidiary of Guotai Haitong Securities that operates through direct private equity fund management and by initiating private equity funds as a fund of funds.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| 光本位科技 | Apr 2026 | Series B | Co-investor |
| 北京天圣华信息技术股份有限公司 | Oct 2025 | Series D | Lead |
| Healsun Biopharm | Aug 2022 | Series B | Co-investor |
| Liaoning Zhonglan Electronic Technology Co., Ltd. | May 2021 | Series B Extension | Co-investor |
| Pachira Information Technology (Beijing) Co., Ltd. | Jul 2017 | Private Placement | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
